Based on our encouraging data with CDC25B specific siRNA, we propose that siRNA may offer a new approach to targeting CDC25B expression and activity in HCC and other malignancies, leading to inhibitions of tumor cell growth and invasion. This evidence concerns the gene CDC25B and neoplasm.